Philippe Camus, M.D.

Dijon, France

Back to drug

The Drug-Induced Respiratory Disease Website

I.a

Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)

Can be fatal (PMID 29912044)

Publications

Gürdo?an M, Yalta K, Gürlertop Y, Karahan F, Bulburu ?B, Koçyi?it B, Ustaba??o?lu FE, Çiçin ?

Coexistence of Anti-PD1-Induced Immune Myocarditis and Complete Atrioventricular Block: A Case Report.

The American journal of cardiology 2023 Sep 16;207;35-38 — 2023 Sep 16 — 35-38

Mascolo A, Scavone C, Ferrajolo C, Rafaniello C, Danesi R, Del Re M, Russo A, Coscioni E, Rossi F, Alfano R, Capuano A

Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance.

Drug safety 2021 Jun 18;; — 2021 Jun 18

Mir H, Alhussein M, Alrashidi S, Alzayer H, Alshatti A, Valettas N, Mukherjee SD, Nair V, Leong DP

Cardiac Complications Associated With Checkpoint Inhibition: A Systematic Review of the Literature in an Important Emerging Area.

The Canadian journal of cardiology 2018 08;34;1059-1068 — 2018 08 — 1059-1068

Escudier M, Cautela J, Malissen N, Ancedy Y, Orabona M, Pinto J, Monestier S, Grob JJ, Scemama U, Jacquier A, Lalevee N, Barraud J, Peyrol M, Laine M, Bonello L, Paganelli F, Cohen A, Barlesi F, Ederhy S, Thuny F

Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity.

Circulation 2017 11 21;136;2085-2087 — 2017 11 21 — 2085-2087